| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥591.9B | ¥571.3B | +3.6% |
| Operating Income | ¥28.9B | ¥13.4B | +116.4% |
| Ordinary Income | ¥36.8B | ¥21.5B | +71.0% |
| Net Income | ¥23.0B | ¥15.4B | +48.6% |
| ROE | 3.0% | 2.0% | - |
FY2026 Q3 cumulative results for Mandom Corporation showed revenue of ¥59.19B (YoY +3.6%), operating income of ¥2.89B (+116.4%), ordinary income of ¥3.68B (+71.0%), and net income of ¥2.30B (+48.6%). The dramatic operating income improvement of ¥1.55B year-over-year was driven by gross margin expansion to 46.7% and selling, general and administrative expense control. Non-operating income contributed ¥0.79B net, including interest income of ¥0.35B and dividend income of ¥0.11B, supporting ordinary profit levels. The operating profit margin improved 2.4 percentage points to 4.9% from 2.3% in the prior year period, reflecting operational leverage benefits from revenue growth combined with cost management initiatives.
Revenue increased ¥2.06B or 3.6% year-over-year to ¥59.19B, with growth observed across geographic segments. Segment analysis reveals that the Japan segment generated ¥35.41B in revenue (up ¥0.19B or +0.6% YoY), representing approximately 53% of total segment revenue and serving as the core domestic market. The Indonesia segment recorded ¥14.39B in revenue (up ¥1.65B or +12.9% YoY), demonstrating strong double-digit growth in this key overseas market. Other Overseas segment contributed ¥16.83B (down ¥0.23B or -1.3% YoY), experiencing a modest decline that may reflect regional market conditions or foreign exchange headwinds. The revenue expansion was primarily driven by Indonesia's recovery and sustained domestic market presence, though Other Overseas weakness partially offset gains.
Operating income surged to ¥2.89B from ¥1.34B, representing a 116.4% increase. This dramatic improvement stemmed from gross profit expansion of ¥3.03B to ¥27.67B (gross margin 46.7% versus 43.2% prior year), suggesting favorable product mix, cost of goods sold efficiency gains, or pricing improvements. Selling, general and administrative expenses increased only ¥1.48B to ¥24.78B despite revenue growth, indicating effective cost control with SG&A ratio declining to 41.9% from 40.7%. The operating leverage effect was substantial, with each yen of revenue growth contributing disproportionately to operating profit. Segment profitability analysis shows Japan operating income of ¥1.55B (up ¥0.17B or +12.3% YoY), Indonesia turning to ¥0.29B profit from a ¥1.32B loss in the prior year, and Other Overseas generating ¥1.09B (down ¥0.26B or -19.6% YoY). Indonesia's dramatic turnaround from loss to profit was the primary driver of consolidated operating income growth.
Ordinary income of ¥3.68B exceeded operating income by ¥0.79B, with non-operating items contributing positively. Interest income of ¥0.35B and dividend income of ¥0.11B reflected returns on substantial cash holdings, while equity method investment income and foreign exchange fluctuations also influenced the non-operating result. The gap between ordinary and net income of ¥1.38B (approximately 37.5% of ordinary income) was driven by corporate tax expense of ¥0.99B and extraordinary losses of ¥0.55B. The extraordinary losses, while material, did not include impairment or goodwill write-offs according to segment notes, suggesting other one-time items. Net income of ¥2.30B represented 3.9% net margin, a 1.2 percentage point improvement from the prior year's 2.7%, though remaining below the 6.3% industry median.
This represents a revenue up, profit up pattern, with both top-line and bottom-line expansion. The profit growth significantly outpaced revenue growth, driven by operational leverage, gross margin improvement, and Indonesia's profitability recovery from loss to profit status.
The Japan segment generated revenue of ¥35.41B and operating income of ¥1.55B, representing a 4.4% operating margin. As the largest segment by revenue share at approximately 53% of total segment sales, Japan serves as the core business with stable domestic market presence. The segment showed modest revenue growth of 0.6% YoY while operating profit improved 12.3%, indicating margin expansion through cost efficiency.
The Indonesia segment recorded revenue of ¥14.39B with operating income of ¥0.29B, achieving a 2.0% operating margin. This represents a dramatic turnaround from the prior year's operating loss of ¥1.32B, with the segment achieving profitability through restructuring or market recovery. Revenue growth of 12.9% YoY demonstrates strong market expansion in this strategic overseas market, though profitability remains below Japan's margin level.
The Other Overseas segment contributed revenue of ¥16.83B and operating income of ¥1.09B, yielding a 6.5% operating margin that represents the highest profitability among the three segments. Despite revenue declining 1.3% YoY, this segment maintains strong margin characteristics. Operating profit decreased 19.6% from the prior year, suggesting that the revenue decline disproportionately impacted profitability or that cost structure adjustments have not yet matched the revenue trend.
Material margin differences exist across segments, with Other Overseas achieving 6.5% operating margin compared to Japan's 4.4% and Indonesia's 2.0%. The consolidated operating margin of 4.9% reflects the weighted contribution of these segments. Indonesia's recovery to profitability was the primary driver of consolidated operating income growth, while Japan provided stability and Other Overseas contributed margin quality despite volume softness.
[Profitability] Operating margin of 4.9% improved 2.4 percentage points from 2.3% in the prior year, though remaining below the manufacturing industry median of 8.3%. Net profit margin of 3.9% increased 1.2 percentage points from 2.7% YoY, but also trails the industry median of 6.3%. Return on equity of 2.8% reflects the combination of net profit margin 3.6%, total asset turnover 0.615, and financial leverage 1.25, with ROE remaining below the industry median of 5.0%. Return on assets of 2.3% compares to industry median of 3.3%, while return on invested capital of 2.8% falls short of the 5.0% industry median. Gross profit margin expansion to 46.7% from 43.2% represents a significant 3.5 percentage point improvement. [Cash Quality] Cash and cash equivalents of ¥44.26B provide substantial liquidity, with short-term debt coverage of 4,972 times given minimal interest-bearing debt of ¥0.09B. Operating cash flow to net income ratio of 1.65 indicates healthy cash generation backing reported earnings. Cash conversion ratio of 0.62 suggests room for improvement in converting EBITDA to operating cash flow. [Investment Efficiency] Total asset turnover of 0.615 aligns closely with the industry median of 0.58, indicating typical asset utilization for the manufacturing sector. Working capital management shows inventory turnover of 134 days substantially exceeding the industry median of 109 days, while receivables turnover of 68 days is more efficient than the 83-day industry median. Cash conversion cycle of 137 days reflects the elevated inventory position. Capital expenditure to depreciation ratio of 0.37 falls well below the industry median of 1.44, signaling potential underinvestment in asset renewal. [Financial Health] Equity ratio of 80.2% significantly exceeds the industry median of 63.8%, indicating strong capital adequacy. Current ratio of 453.0% and quick ratio of 350.7% provide substantial liquidity cushion versus industry median of 2.84. Debt-to-equity ratio of 0.001 and net debt to EBITDA of -1.07 (net cash position) reflect minimal leverage compared to industry median net debt to EBITDA of -1.11. Interest coverage ratio exceeds 120 times on an operating income basis.
Operating cash flow of ¥3.51B represents 1.65 times net income of ¥2.12B, confirming earnings quality with cash generation exceeding accounting profit. This ratio exceeds the manufacturing industry median cash conversion ratio of 1.24, demonstrating above-average ability to convert profit into cash. The operating cash flow reflects core business cash generation strength despite working capital pressures from elevated inventory levels. Investing cash flow activities consumed ¥2.17B during the nine-month period, primarily driven by capital expenditures of ¥1.04B alongside other investment activities. The CapEx level of ¥1.04B compares to depreciation and amortization of ¥2.81B, yielding a CapEx to depreciation ratio of 0.37 that falls substantially below the industry median of 1.44, suggesting conservative investment in asset replacement and capacity expansion. Free cash flow of ¥1.34B represents operating cash flow less investing activities, providing funds available for shareholder returns and debt reduction. However, the FCF coverage ratio of 0.69 indicates that free cash flow alone would be insufficient to fully cover expected annual dividend payments at current levels. Financing activities are not fully detailed in the quarterly statement, but the company's minimal debt and strong equity base indicate flexible financing capacity. Cash and deposits increased to ¥44.26B from prior levels, supported by operating profit growth and working capital contributions. The net cash position of ¥44.17B (cash minus interest-bearing debt of ¥0.09B) represents negative net debt to EBITDA of -1.07, providing substantial financial flexibility. Working capital efficiency shows mixed signals, with accounts receivable of ¥10.92B representing 68 days sales outstanding that is better than industry median, while inventory of ¥13.62B translates to 134 days inventory outstanding that exceeds industry norms and ties up working capital. The combination yields a cash conversion cycle of 137 days, indicating room for improvement through inventory optimization.
Ordinary income of ¥3.68B compared to operating income of ¥2.89B indicates non-operating net contribution of approximately ¥0.79B, representing 21.5% of operating income or 1.3% of revenue. The non-operating section comprises primarily interest income of ¥0.35B, dividend income of ¥0.11B, and equity method investment income of ¥0.16B as positive contributors, partially offset by interest expenses of ¥0.03B and other non-operating expenses. Financial income from interest and dividends totaling ¥0.46B reflects returns on the substantial cash position of ¥44.26B. Foreign exchange gains or losses are embedded in non-operating items but are not separately quantified in available data, though they represent a recurring element given overseas operations exposure. The composition suggests that non-operating income is largely recurring in nature from financial assets, though subject to market rate fluctuations. Operating cash flow of ¥3.51B exceeds net income of ¥2.12B by a ratio of 1.65, indicating healthy earnings quality with profit generation backed by cash collection. This comparison suggests that accruals are working favorably, with depreciation and working capital changes contributing positively to cash flow. The cash conversion ratio from EBITDA to operating cash flow stands at 0.62, which is below the industry median of 1.24 and indicates that approximately 38% of EBITDA is absorbed by working capital, interest, or taxes before converting to operating cash flow. Extraordinary losses of ¥0.55B were recorded in the period, though segment notes confirm no material impairment losses or goodwill write-offs were recognized. The extraordinary items represent 2.3% of ordinary income and 15.0% of net income, warranting attention as a non-recurring factor affecting bottom-line results. The absence of large-scale asset impairments or restructuring charges supports the assessment that core operational earnings quality is sound, though working capital efficiency requires monitoring.
Full-year guidance calls for revenue of ¥78.6B, operating income of ¥2.70B, ordinary income of ¥3.60B, and net income attributable to owners of ¥2.10B. Nine-month cumulative results show revenue of ¥59.19B representing 75.3% progress, operating income of ¥2.89B representing 107.0% progress, ordinary income of ¥3.68B representing 102.2% progress, and net income of ¥2.30B representing 109.5% progress against full-year targets. The progress rates substantially exceed the standard 75% benchmark for Q3, indicating stronger-than-expected performance in the first nine months. Operating income already exceeds the full-year target by 7.0 percentage points, suggesting either conservative initial guidance or exceptional performance that may lead to an upward revision. Similarly, ordinary income and net income have surpassed annual targets, with net income exceeding forecast by 9.5 percentage points. Revenue progress of 75.3% aligns closely with the 75% standard Q3 rate, indicating on-track top-line performance. The company's year-over-year guidance assumes revenue growth of 3.2%, operating income growth of 162.6%, and ordinary income growth of 65.1%, reflecting expectations of significant profitability improvement from prior year base. The substantial ahead-of-schedule progress on profit metrics suggests potential for fourth quarter results to further exceed initial expectations or that Q4 seasonality may moderate from Q1-Q3 run rates. Key assumptions from forecast notes are not detailed in the provided data, though the dramatic operating leverage implied in guidance aligns with observed Q3 results. Investors should monitor whether the company revises guidance upward given current performance trajectory or maintains conservative targets reflecting Q4 uncertainty.
Annual dividend is planned at ¥40 per share, comprising interim dividend of ¥20 and year-end dividend of ¥20. This represents a ¥5 increase from the prior year's total annual dividend of ¥35 per share, indicating a 14.3% year-over-year dividend growth. Based on reported net income of ¥2.30B and approximately 48.27 million shares outstanding, the payout ratio calculates to approximately 91.0%, representing a high level of earnings distribution to shareholders. The elevated payout ratio substantially exceeds the company's historical average and raises questions about dividend sustainability if earnings were to decline or if capital investment needs increase. However, the company's substantial cash position of ¥44.26B and minimal debt of ¥0.09B provide near-term capacity to maintain dividends even if earnings fluctuate. Free cash flow of ¥1.34B yields an FCF coverage ratio of 0.69 against estimated annual dividend payments, indicating that dividends would exceed free cash flow generation at current run rates. This suggests dividends are being supported in part by balance sheet cash rather than fully from current period free cash flow, which is sustainable in the near term given cash reserves but could constrain future flexibility. No share buyback programs are disclosed in the available data. The total shareholder return therefore consists primarily of the dividend yield, which would represent approximately 3-4% depending on share price levels. The dividend policy appears to prioritize shareholder returns at current elevated payout levels, though the sustainability of 91% payout warrants monitoring alongside capital expenditure needs and business investment requirements. The combination of high payout ratio and low CapEx to depreciation ratio of 0.37 suggests capital allocation is heavily weighted toward shareholder returns rather than business reinvestment, which may benefit near-term returns but could impact long-term growth capacity.
Inventory management risk represents a significant operational concern, with inventory levels of ¥13.62B translating to 134 days inventory outstanding that exceeds the manufacturing industry median of 109 days by 23%. Elevated inventory ties up working capital and increases exposure to obsolescence, markdown, or demand shift risks. The cosmetics and toiletries industry faces product lifecycle and consumer preference volatility, amplifying the risk that excess inventory could require writedowns. Working capital efficiency deterioration is evidenced by the cash conversion cycle of 137 days, and inventory reduction initiatives should be monitored as a key operational priority.
Market and competitive risks stem from intensifying competition in both domestic and overseas cosmetics markets, particularly in Indonesia and Other Overseas segments where revenue growth has been uneven. The Japan segment's modest 0.6% revenue growth reflects mature domestic market conditions and potential market share pressures. Changing consumer preferences toward e-commerce channels, premium or natural product categories, and demographic shifts in core markets could impact demand patterns. The Other Overseas segment's 1.3% revenue decline in the period highlights vulnerability to regional market dynamics and competitive positioning challenges in certain geographies.
Capital allocation sustainability risk arises from the combination of high dividend payout ratio of 91% and low capital expenditure to depreciation ratio of 0.37. This capital allocation pattern maximizes current shareholder returns but constrains investment in production capacity, equipment renewal, and growth initiatives. The manufacturing industry median CapEx to depreciation ratio of 1.44 suggests peers are investing at replacement-plus-growth rates, whereas Mandom's 0.37 ratio indicates potential underinvestment. Sustained underinvestment could lead to equipment aging, production efficiency degradation, or inability to support new product launches, ultimately impacting competitive positioning and revenue growth capacity over a 3-5 year horizon.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics show Mandom operating margin of 4.9% remains below the manufacturing industry median of 8.3%, indicating lower operational efficiency or more competitive market conditions compared to industry peers. Net profit margin of 3.9% similarly trails the industry median of 6.3% by 2.4 percentage points, reflecting relatively compressed margins. Return on equity of 2.8% falls short of the industry median of 5.0%, suggesting lower capital productivity. Return on assets of 2.3% versus industry median of 3.3% and return on invested capital of 2.8% versus industry median of 5.0% further confirm below-median profitability across multiple dimensions. The profitability gap indicates Mandom operates in a more commoditized or competitive segment of manufacturing, or faces structural cost challenges limiting margin expansion.
Financial health metrics position Mandom favorably relative to industry benchmarks. Equity ratio of 80.2% substantially exceeds the industry median of 63.8%, indicating stronger capital adequacy and lower financial leverage. Current ratio of 453.0% versus industry median of 2.84 reflects exceptional liquidity, with Mandom holding nearly 16 times more current assets relative to current liabilities than typical industry peers. Net debt to EBITDA of -1.07 (net cash position) compares to industry median of -1.11, showing similar conservative balance sheet positioning. The minimal leverage and high equity ratio provide substantial financial flexibility and resilience to earnings volatility.
Efficiency metrics show mixed positioning. Total asset turnover of 0.615 aligns closely with industry median of 0.58, indicating typical asset utilization for manufacturing sector. However, inventory turnover of 134 days substantially exceeds the industry median of 109 days by 23%, highlighting relative inefficiency in inventory management. Receivables turnover of 68 days compares favorably to industry median of 83 days, demonstrating stronger collection efficiency. Capital expenditure to depreciation ratio of 0.37 falls far below the industry median of 1.44, indicating Mandom is investing at less than half the pace of industry peers in maintaining and expanding productive assets.
Growth trajectory shows revenue growth of 3.6% YoY modestly exceeding the industry median of 2.7%, indicating slightly above-average top-line momentum. However, the elevated profitability growth driven by Indonesia turnaround represents a specific recovery situation rather than sustained competitive advantage. The Rule of 40 metric combining growth and profitability would approximate 8.5% (3.6% revenue growth plus 4.9% operating margin), falling short of the industry median of 11% and well below the 40% benchmark used in high-growth sectors.
※ Industry: Manufacturing (98 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis
Mandom's Q3 FY2026 results demonstrate significant operational improvement with operating income more than doubling year-over-year, primarily driven by Indonesia segment's recovery from loss to profitability and gross margin expansion of 3.5 percentage points. The operating leverage effect from revenue growth combined with cost control initiatives has delivered operating margin improvement to 4.9% from 2.3%, though this remains below the 8.3% manufacturing industry median and indicates continued room for efficiency enhancement. The profitability recovery represents a meaningful positive development, with sustainability depending on whether gross margin gains reflect structural improvements in product mix and pricing power or temporary cost benefits.
Balance sheet strength represents a distinctive characteristic, with equity ratio of 80.2% and net cash position of ¥44.17B providing substantial financial flexibility that exceeds industry norms. Current ratio of 453.0% and minimal leverage create resilience to earnings volatility and capacity for strategic initiatives. However, this financial conservatism combined with capital expenditure at only 37% of depreciation levels raises questions about optimal capital deployment. The 91% dividend payout ratio channels earnings predominantly to shareholders rather than business reinvestment, which may constrain long-term growth capacity despite supporting near-term shareholder returns.
Working capital efficiency deterioration presents a key operational concern requiring management attention. Inventory turnover of 134 days exceeds industry median by 23% and has triggered multiple warning signals in cash conversion metrics. The elevated inventory position of ¥13.62B ties up capital that could otherwise fund growth initiatives or enhance returns, and increases exposure to product obsolescence risk in the cosmetics industry. Inventory optimization initiatives would simultaneously improve return on invested capital, cash conversion cycle, and financial flexibility. The contrast between strong cash generation (operating CF to net income ratio of 1.65) and suboptimal working capital efficiency suggests addressable operational improvement opportunities that could enhance overall financial performance and shareholder value creation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.